BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11874521)

  • 1. Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep.
    Sánchez S; Small J; Jones DG; McKellar QA
    J Vet Pharmacol Ther; 2002 Feb; 25(1):7-13. PubMed ID: 11874521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses.
    Sánchez Bruni SF; Fusé LA; Moreno L; Saumell CA; Alvarez LI; Fiel C; McKellar QA; Lanusse CE
    Equine Vet J; 2005 May; 37(3):257-62. PubMed ID: 15892236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenbendazole pharmacokinetics, metabolism, and potentiation in horses.
    McKellar QA; Gokbulut C; Muzandu K; Benchaoui H
    Drug Metab Dispos; 2002 Nov; 30(11):1230-9. PubMed ID: 12386129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1995 Jun; 18(3):196-203. PubMed ID: 7674455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of formulation concentration on intravenous pharmacokinetics, chirality and in vitro solubility of oxfendazole and its metabolites in sheep.
    Sánchez Bruni SF; Jones DG; Small J; McKellar QA
    J Vet Pharmacol Ther; 2005 Oct; 28(5):467-73. PubMed ID: 16207310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic interaction between oxfendazole and triclabendazole: In vitro biotransformation and systemic exposure in sheep.
    Viviani P; Lifschitz AL; Luque SE; Lloberas MM; Maté ML; Cardozo PA; Lanusse CE; Virkel GL
    Exp Parasitol; 2019 Sep; 204():107718. PubMed ID: 31201779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an oil formulation on the systemic availability of oxfendazole.
    Ali DN; Chick BF
    Int J Parasitol; 1992 Jul; 22(4):541-3. PubMed ID: 1644532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pharmacokinetic interactions between piperonyl butoxide and albendazole against gastrointestinal nematodiasis in goats.
    Kumbhakar NK; Sanyal PK; Rawte D; Kumar D; Kerketta AE; Pal S
    J Helminthol; 2016 Sep; 90(5):624-9. PubMed ID: 26566193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone decreases plasma levels of the prochiral fenbendazole and its chiral and achiral metabolites in sheep.
    Sánchez S; Small J; Jones DG; McKellar QA
    Xenobiotica; 2003 Jul; 33(7):731-42. PubMed ID: 12893522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diet variations on the kinetic disposition of oxfendazole in sheep.
    Oukessou M; Chkounda S
    Int J Parasitol; 1997 Nov; 27(11):1347-51. PubMed ID: 9421722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of feed type on the pharmacokinetic disposition of oxfendazole in sheep.
    Ali DN; Chick BF
    Res Vet Sci; 1992 May; 52(3):382-3. PubMed ID: 1620973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of co-administration of parbendazole on the disposition of oxfendazole in sheep.
    Hennessy DR; Steel JW; Prichard RK; Lacey E
    J Vet Pharmacol Ther; 1992 Mar; 15(1):10-8. PubMed ID: 1573698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro ruminal biotransformation of benzimidazole sulphoxide anthelmintics: enantioselective sulphoreduction in sheep and cattle.
    Virkel G; Lifschitz A; Pis A; Lanusse C
    J Vet Pharmacol Ther; 2002 Feb; 25(1):15-23. PubMed ID: 11874522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxfendazole in goats: a comparison with sheep.
    Bogan J; Benoit E; Delatour P
    J Vet Pharmacol Ther; 1987 Dec; 10(4):305-9. PubMed ID: 3437495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic assessment of the monepantel plus oxfendazole combined administration in dairy cows.
    Ballent M; Viviani P; Imperiale F; Dominguez P; Halwachs S; Mahnke H; Honscha W; Lanusse C; Virkel G; Lifschitz A
    J Vet Pharmacol Ther; 2018 Apr; 41(2):292-300. PubMed ID: 29139145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep.
    Lanusse CE; Gascon LH; Prichard RK
    Res Vet Sci; 1995 May; 58(3):222-6. PubMed ID: 7659845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep.
    Virkel G; Lifschitz A; Sallovitz J; Ballent M; Scarcella S; Lanusse C
    J Vet Pharmacol Ther; 2009 Feb; 32(1):79-86. PubMed ID: 19161459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles.
    Moreno L; Lopez-Urbina MT; Farias C; Domingue G; Donadeu M; Dungu B; García HH; Gomez-Puerta LA; Lanusse C; González AE
    Food Chem Toxicol; 2012 Oct; 50(10):3819-25. PubMed ID: 22841955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.